In this role you contribute to early psychosis participant assessments and evaluate CBD as a potential treatment within a clinical trial. You will join ongoing international research and have opportunities to develop your own academic and clinical interests. The position sits in the Department of Psychiatry at the Warneford Hospital and is funded for three years, with part-time options. You will work closely with a renowned research group focused on psychosis mechanisms and novel treatments.
Pay / Benefits
Excellent contributory pension scheme
38 days annual leave
Comprehensive childcare services
Family leave schemes
Cycle loan scheme
Discounted bus travel and travel loans
Responsibilities
Assess participants in early psychosis and healthy controls
Contribute to evaluating CBD as a treatment in a clinical trial
Engage with ongoing projects and develop personal academic/clinical interests
Collaborate with cross-functional research teams on study protocols and data collection
Key requirements
Medical degree (MBBS/MD or equivalent) and Foundation training completed
Demonstrable strong interest in psychiatric research
Excellent communication skills and ability to engage difficult-to-engage participants
Desirable: MRCPsych or equivalent
Excellent communication
Rapport-building with challenging participants
Collaborative mindset
Clinical trial conduct and participant assessment
Psychoeducation and patient assessment in psychiatric settings
Data collection and basic analysis in clinical research
We use essential cookies to make this site work. With your permission we would also like to use the optional cookies below. Nothing optional is set until you choose, and you can change your mind at any time from "Cookie settings" at the bottom of every page. Cookie policy.
Essential — keep the site working and secure, and remember the choice you make here. Always on.